View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
A fast, accurate device that lets patients measure hemoglobin A1C levels at home has received Food and Drug Administration approval. The pager-sized monitor, which measures both A1C and total hemoglobin, activates when the patient applies a finger-stick blood sample to its sample port. Results appear within 8 minutes.
Easy to use, the device requires no test strips or maintenance. Its accuracy is similar to that of lab test results, which may not be available for several days. Using it at the bedside or in an outpatient setting, you can discuss findings with your patient on the spot and adjust antidiabetic medication as indicated.
For more information about the A1CNow monitor, go to http://www.metrika.com.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top